Trials / Terminated
TerminatedNCT03555721
CytID Analysis of Oral Lesions
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to correlate the results from a standard of care biopsy with CytID™ and hpvID™ swab tests for potentially premalignant and malignant oral lesions. The biopsy is considered standard of care and will be performed regardless of the patient's enrollment in the study. The study-related data gathering will not influence the treatment decisions of the clinician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oral examination with incandescent light | Suspicious oral lesions will be identified by oral examination with incandescent light. |
| OTHER | Oral examination with OralID | OralID uses a proven, optically based fluorescence technology that provides the clinician an aid in visualization of oral cancer, pre-cancer and other abnormal lesions. |
| DIAGNOSTIC_TEST | Biopsy | Tissue will be collected to identify pre-cancerous or cancerous cells |
| DIAGNOSTIC_TEST | CytID | CytID™ is an adjunctive process that is a noninvasive, pain-free, chair-side procedure for assessment of suspicious oral cavity lesions using a brush swab. The test is based on an objective measure of gross changes in the nuclear DNA content of oral epithelial cells; thereby, providing information about the pre-cancerous or cancerous state of a lesion. |
| DIAGNOSTIC_TEST | hpvID | hpvID™ testing can detect all major HPV types and shows the current HPV status of the patient. This provides additional clinical information to correlate and compare hpvID™ trends with routine standard of care biopsy or cytology results. |
Timeline
- Start date
- 2018-05-30
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
- First posted
- 2018-06-13
- Last updated
- 2023-05-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03555721. Inclusion in this directory is not an endorsement.